Plasma insulin-like growth factor I levels in the elderly: Relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality

被引:22
|
作者
Raynaud-Simon, A [1 ]
Lafont, S
Berr, C
Dartigues, JF
Baulieu, EE
Le Bouc, Y
机构
[1] Hop Charles Foix, Unite Med Nutr Geriatr, AP HP, F-94205 Ivry, France
[2] Hop Trousseau, Lab Explorat Fonctionnelles Endocriniennes, Paris, France
[3] Hop St Antoine, F-75571 Paris, France
[4] Univ Bordeaux 2, INSERM U330, Bordeaux, France
[5] Hop La Pitie Salpetriere, INSERM U360, Paris, France
[6] Hop Bicetre, INSERm U488, Le Kremlin Bicetre, France
关键词
insulin-like growth factor I; aging dehydroepiandrosterone sulfate; nutrition; mortality; cognition; depression; functional disability;
D O I
10.1159/000052799
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Insulin-like growth factor I (IGF-I) has beneficial metabolic effects. Because plasma IGF-I levels have been reported to be enhanced by dehydroepiandrosterone (DHEA) administration, it has been suggested that the IGF-I may be implicated in some of the reported associations between low DHEA sulfate (DHEAS) levels and impaired health measures in elderly subjects. The nutritional status, which also regulates plasma IGF-I levels, is also an important determinant of health outcome. Objective:We sought to investigate the associations between plasma IGF-I revels and plasma DHEAS levels, nutritional status, health, and mortality in the elderly. Methods: In 256 community-dwelling subjects aged 65-101 years, enrolled in the Paquid study, a health questionnaire was used to a certain their functional disabilities, any history of medical disorders, self-perceived health, depressive symptoms, and their cognitive function. Biological measurements included levels of plasma IGF-I, albumin, transthyretin, and DHEAS. Mortality data were available for 6 years following blood sampling. Results: In this elderly population with no impairment in nutritional status, the plasma IGF-I levels decreased significantly with age (p = 0.02). The plasma IGF-I levels correlated positively with those of transthyretin (p = 0.0001). IGF-I also correlated with DHEAS (p = 0.04), but the correlation did not remain significant after adjustment for age. As opposed to SDHEA, the plasma IGF-I revels did not correlate with the results from the hearth questionnaire. The baseline IGF-I values in the highest tertile were associated with a higher risk of short-term mortality than those in the lowest tertile (RR = 8.4 at 2 years, p = 0.007). Conclusions: Our results suggest that IGF-I is not connected with the association between low plasma DHEAS levels and the impaired results from the health questionnaire. The relationship between plasma IGF-I highest levels and mortality should be further explored. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:198 / 206
页数:9
相关论文
共 50 条
  • [21] Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children
    Besbas, N
    Ozaltin, F
    Coskun, T
    Özalp, S
    Saatçi, U
    Bakkaloglu, A
    El Nahas, AM
    PEDIATRIC NEPHROLOGY, 2003, 18 (12) : 1255 - 1259
  • [22] SERUM LEVELS AND MOLECULAR SIZES OF GROWTH-HORMONE DURING PREGNANCY IN RELATION TO LEVELS OF LACTOGENS, INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1
    LUTHMAN, M
    BREMME, K
    JONSDOTTIR, I
    HALL, K
    ROOS, P
    WERNER, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1991, 31 (02) : 67 - 73
  • [23] Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children
    Bideci, A
    Cinaz, P
    Hasanoglu, A
    Elbeg, S
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 (03) : 295 - 299
  • [24] SIZE AT BIRTH AND PLASMA INSULIN-LIKE GROWTH-FACTOR-I CONCENTRATIONS
    FAIL, CHD
    PANDIT, AN
    LAW, CM
    YAJNIK, CS
    CLARK, PM
    BREIER, B
    OSMOND, C
    SHIELL, AW
    GLUCKMAN, PD
    BARKER, DJP
    ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (04) : 287 - 293
  • [25] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis
    Toussirot, E
    Nguyen, NU
    Dumoulin, G
    Regnard, J
    Wendling, D
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (11): : 1172 - 1176
  • [26] INSULIN-LIKE GROWTH FACTOR-I (IGF-1) AND DEHYDROEPIANDROSTERONE-SULFATE IN OBESE WOMEN
    DEPERGOLA, G
    COSPITE, MR
    GIAGULLI, VA
    GIORGINO, F
    GARRUTI, G
    CIGNARELLI, M
    GIORGINO, R
    INTERNATIONAL JOURNAL OF OBESITY, 1993, 17 (08) : 481 - 483
  • [27] Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure
    Andreassen, Mikkel
    Kistorp, Caroline
    Raymond, Ilan
    Hildebrandt, Per
    Gustafsson, Finn
    Kristensen, Lars Ostergaard
    Faber, Jens
    GROWTH HORMONE & IGF RESEARCH, 2009, 19 (06) : 486 - 490
  • [28] Insulin-Like Growth Factor I, Insulin-like Growth factor Binding Protein 3, and Atrial Fibrillation in the Elderly
    Duron, Emmanuelle
    Vidal, Jean-Sebastien
    Funalot, Benoit
    Brunel, Nadege
    Viollet, Cecile
    Seux, Marie-Laure
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    Le Bouc, Yves
    Hanon, Olivier
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2014, 69 (08): : 1025 - 1032
  • [29] The relation between nutritional factors and insulin-like growth factor-I in premenopausal women of different ethnicity
    Maskarinec, G
    Takata, Y
    Kaaks, R
    EUROPEAN JOURNAL OF NUTRITION, 2005, 44 (02) : 105 - 113
  • [30] Does attainment of target levels of growth hormone and insulin-like growth factor I improve acromegaly prognosis?
    Chanson, Philippe
    Maison, Patrick
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (02): : 70 - 71